Figure 1.

Experimental protocol for the studies involving Z13752A, and its modification by icatibant, an antagonist of bradykinin at B2 receptors. The duration of the Z13752A infusion was 1 h, the occlusion time was 25 min and icatibant was given 10 min prior to occlusion.